All In MedTech

FDA Clearance Tracker · P080011-S112

Natural Eyes HydraWear™ XW Multifocal

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 7, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P080011-S112
Device name
Natural Eyes HydraWear™ XW Multifocal
Applicant location
San Ramon, CA
Received
Jul 20, 2020
Decided
Jan 7, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P080011

Device type

Device class
Class III
Regulation
21 CFR 886.5925
Specialty
Ophthalmology

Every decision under product code LPM

FDA's approval statement

As written in FDA's record.

Approval for a new private label trade name, Natural Eyes HydraWear XW Multifocal, for the CooperVision comfilcon A soft (hydrophilic) contact lenses for extended wear.

Source documents

Other decisions for CooperVision, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.